Glenmede Trust CO Na Teva Pharmaceutical Industries LTD Transaction History

Glenmede Trust CO Na

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $18,296 - $23,460	-2,125 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $351 - $520	41 Added 1.97%	2,125 $18,000
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $3,426 - $5,536	-422 Reduced 16.84%	2,084 $24,000
Q4 2019 Feb 12, 2020	SELL	$6.53 - $10.72 $9,142 - $15,008	-1,400 Reduced 35.84%	2,506 $23,000
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $7,626 - $11,884	-1,238 Reduced 24.07%	3,906 $26,000
Q2 2019 Aug 13, 2019	SELL	$8.12 - $15.72 $105,438 - $204,124	-12,985 Reduced 71.63%	5,144 $47,000
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $1,480 - $1,900	-95 Reduced 0.52%	18,129 $284,000
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $39,042 - $63,795	2,676 Added 17.21%	18,224 $280,000
Q3 2018 Nov 15, 2018	SELL	$21.06 - $25.65 $800 - $974	-38 Reduced 0.24%	15,548 $334,000
Q2 2018 Aug 15, 2018	SELL	$16.77 - $24.71 $118,781 - $175,020	-7,083 Reduced 31.25%	15,586 $379,000
Q4 2017 Feb 15, 2018	SELL	$11.23 - $19.1 $26,457 - $44,999	-2,356 Reduced 9.41%	22,669 $429,000
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $385,635 - $805,054	25,025	25,025 $0

604

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.